STOCK TITAN

[Form 4] AXON ENTERPRISE, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc. (AXON), reported a sale of 77 shares of common stock on 09/15/2025. The sale was effected under a Rule 10b5-1 trading plan adopted March 14, 2025, and related to shares issued upon settlement of vested restricted stock units. The reported sale price was $760 per share. After the transaction, Ms. Mak beneficially owned 15,003 shares directly. The Form 4 was signed by an attorney-in-fact on her behalf.

Jennifer H. Mak, Amministratrice capo della contabilità di Axon Enterprise, Inc. (AXON), ha riferito della vendita di 77 azioni ordinarie il 15/09/2025. La vendita è stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 14 marzo 2025, e relativa alle azioni emesse al regolamento di unità azionarie vincolate vestite. Il prezzo di vendita riportato è stato di 760 dollari per azione. Dopo la transazione, la signora Mak detiene direttamente 15.003 azioni. Il Modello 4 è stato firmato da un procuratore-in-fatto per suo conto.
Jennifer H. Mak, Directora de Contabilidad de Axon Enterprise, Inc. (AXON), informó la venta de 77 acciones ordinarias el 15/09/2025. La venta se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 14 de marzo de 2025, y relacionada con acciones emitidas al liquidarse unidades de acciones restringidas que habían adquirido derechos. El precio de venta reportado fue de 760 dólares por acción. Después de la transacción, la señora Mak poseía directamente 15.003 acciones. El Form 4 fue firmado por un apoderado en su nombre.
Jennifer H. Mak은 Axon Enterprise, Inc. (AXON)최고 회계 책임자로서 2025년 9월 15일에 보통주 77주를 매도했다고 보고했습니다. 매도는 Rule 10b5-1 거래 계획에 따라 이루어졌으며, 2025년 3월 14일에 채택되었고, 베스팅 완료된 제한주식 단위의 정산과 관련이 있습니다. 보고된 매도가의 가격은 주당 760달러였습니다. 거래 후 Mak 씨는 직접적으로 15,003주를 소유했습니다. Form 4는 그녀를 대신하여 대리인이 서명했습니다.
Jennifer H. Mak, Directrice principale de la comptabilité de Axon Enterprise, Inc. (AXON), a signalé la vente de 77 actions ordinaires le 15/09/2025. La vente a été effectuée dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 14 mars 2025, et liée à des actions émises lors du règlement des unités d’actions restreintes acquises. Le prix de vente déclaré était de 760 dollars par action. Après la transaction, Mme Mak détenait directement 15 003 actions. Le Formulaire 4 a été signé par un mandataire en son nom.
Jennifer H. Mak, Chief Accounting Officer von Axon Enterprise, Inc. (AXON), meldete den Verkauf von 77 Stammaktien am 15.09.2025. Der Verkauf erfolgte im Rahmen eines Rule-10b5-1-Handelsplans, der am 14. März 2025 verabschiedet wurde, und stand im Zusammenhang mit Aktien, die bei der Abwicklung vestierter Restricted Stock Units (RSU) ausgegeben wurden. Der gemeldete Verkaufspreis betrug 760 USD pro Aktie. Nach der Transaktion hielt Frau Mak direkt 15.003 Aktien. Das Formular 4 wurde von einem Bevollmächtigten in ihrem Namen unterschrieben.
جينيفر إتش. ماك، كبير مسؤولي المحاسبة في Axon Enterprise, Inc. (AXON)، أبلغت عن بيع 77 سهماً من الأسهم العادية في 15/09/2025. حدث البيع بموجب خطة تداول Rule 10b5-1 التي تم اعتمادها في 14 مارس 2025، والمتعلقة بالأسهم الصادرة عند تسوية وحدات الأسهم المقيدة المكتسبة. كان سعر البيع المبلغ عنه 760 دولاراً للسهم الواحد. بعد الصفقة، امتلكت السيدة ماك مباشرة 15,003 أسهم. تم توقيع النموذج 4 من قبل وكيل مفوَّض نيابة عنها.
Jennifer H. Mak,Axon Enterprise, Inc. (AXON)首席会计官,在2025/09/15报告出售77股普通股。此次出售是在Rule 10b5-1 交易计划下进行,该计划于2025年3月14日通过,与在已归属的限制性股票单位结算时发行的股份有关。报告的出售价格为每股760美元。交易完成后,Mak女士直接持有15,003股。该
由一名代理律师代表她签署。
Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider sale of 77 shares under a 10b5-1 plan; small position reduction relative to reported direct holdings.

The Form 4 discloses a routine, pre-planned disposition under a Rule 10b5-1 trading plan adopted March 14, 2025. The transaction involved 77 shares at $760 each, leaving 15,003 shares beneficially owned directly. Given the small absolute size of the sale versus reported holdings, this filing is a routine insider liquidity event rather than a material change to ownership or governance. No additional compensatory or company-level financial data is included.

TL;DR: Properly documented Rule 10b5-1 sale; disclosure and signature via attorney-in-fact are consistent with standard insider reporting practices.

The filing states the sale was executed pursuant to a 10b5-1 plan and that shares sold derived from settled vested restricted stock units. The inclusion of the plan adoption date and the attorney-in-fact signature indicates compliance with typical insider trading disclosure protocols. There are no indications of unusual timing or material governance events in this Form 4.

Jennifer H. Mak, Amministratrice capo della contabilità di Axon Enterprise, Inc. (AXON), ha riferito della vendita di 77 azioni ordinarie il 15/09/2025. La vendita è stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 14 marzo 2025, e relativa alle azioni emesse al regolamento di unità azionarie vincolate vestite. Il prezzo di vendita riportato è stato di 760 dollari per azione. Dopo la transazione, la signora Mak detiene direttamente 15.003 azioni. Il Modello 4 è stato firmato da un procuratore-in-fatto per suo conto.
Jennifer H. Mak, Directora de Contabilidad de Axon Enterprise, Inc. (AXON), informó la venta de 77 acciones ordinarias el 15/09/2025. La venta se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 14 de marzo de 2025, y relacionada con acciones emitidas al liquidarse unidades de acciones restringidas que habían adquirido derechos. El precio de venta reportado fue de 760 dólares por acción. Después de la transacción, la señora Mak poseía directamente 15.003 acciones. El Form 4 fue firmado por un apoderado en su nombre.
Jennifer H. Mak은 Axon Enterprise, Inc. (AXON)최고 회계 책임자로서 2025년 9월 15일에 보통주 77주를 매도했다고 보고했습니다. 매도는 Rule 10b5-1 거래 계획에 따라 이루어졌으며, 2025년 3월 14일에 채택되었고, 베스팅 완료된 제한주식 단위의 정산과 관련이 있습니다. 보고된 매도가의 가격은 주당 760달러였습니다. 거래 후 Mak 씨는 직접적으로 15,003주를 소유했습니다. Form 4는 그녀를 대신하여 대리인이 서명했습니다.
Jennifer H. Mak, Directrice principale de la comptabilité de Axon Enterprise, Inc. (AXON), a signalé la vente de 77 actions ordinaires le 15/09/2025. La vente a été effectuée dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 14 mars 2025, et liée à des actions émises lors du règlement des unités d’actions restreintes acquises. Le prix de vente déclaré était de 760 dollars par action. Après la transaction, Mme Mak détenait directement 15 003 actions. Le Formulaire 4 a été signé par un mandataire en son nom.
Jennifer H. Mak, Chief Accounting Officer von Axon Enterprise, Inc. (AXON), meldete den Verkauf von 77 Stammaktien am 15.09.2025. Der Verkauf erfolgte im Rahmen eines Rule-10b5-1-Handelsplans, der am 14. März 2025 verabschiedet wurde, und stand im Zusammenhang mit Aktien, die bei der Abwicklung vestierter Restricted Stock Units (RSU) ausgegeben wurden. Der gemeldete Verkaufspreis betrug 760 USD pro Aktie. Nach der Transaktion hielt Frau Mak direkt 15.003 Aktien. Das Formular 4 wurde von einem Bevollmächtigten in ihrem Namen unterschrieben.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Mak Jennifer H

(Last) (First) (Middle)
17800 N 85TH ST

(Street)
SCOTTSDALE AZ 85255

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/15/2025 S(1) 77 D $760 15,003 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This sale, effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, consisted of shares issued upon the settlement of vested restricted stock units.
Remarks:
/s/ Jennifer H. Mak by Isaiah Fields, Attorney-in-Fact 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AXON Chief Accounting Officer Jennifer Mak report on Form 4?

The Form 4 reports a sale of 77 shares of Axon common stock on 09/15/2025, executed under a Rule 10b5-1 trading plan adopted March 14, 2025.

At what price were the AXON shares sold in the Form 4 filed by Jennifer Mak?

The reported sale price was $760 per share.

How many AXON shares did Jennifer Mak own after the reported transaction?

After the sale, she beneficially owned 15,003 shares directly.

Why does the Form 4 mention a Rule 10b5-1 trading plan?

The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted March 14, 2025, indicating the transaction was pre-planned and executed under that program.

Who signed the Form 4 for Jennifer Mak?

The Form 4 is signed by Isaiah Fields, Attorney-in-Fact for Jennifer H. Mak dated 09/15/2025.
Axon Enterprise

NASDAQ:AXON

AXON Rankings

AXON Latest News

AXON Latest SEC Filings

AXON Stock Data

55.91B
75.23M
4.17%
83.3%
2.1%
Aerospace & Defense
Ordnance & Accessories, (no Vehicles/guided Missiles)
Link
United States
SCOTTSDALE